Scientific Events

11th IBRO World Congress of Neuroscience; Granada 9-13th September 2023

Poster: Identification of new targets in an in vitro model of neurodegeneration through the use of activity-based probes. Ania Canseco- Rodriguez et al.
Poster: Neuroinflammation underlies hyperactivity and pain sensitivity in a mice model of ADHD. M. Meseguer-Beltran et al
Poster; FENS travel Award S. Sanchez-Sarasua et al

VIII Jornadas Faculty of Health Science (UJI) April 2023

Maria Meseguer-Beltran. My thesis in 4.59


Annual symposium INAM (UJI).

November 2022.

Sariah Giraldo-Narcizo.


Ania Canseco-Rodriguez participated in DARTER training school: Introduction to nucleic acid therapy. Porto 22-27 October 2022


JORNADA DE ECONOMÍA CIRCULAR: INNOVACIÓN SOSTENIBLE EN LA UCIE-INAM. 15 DE SEPTIEMBRE 2022 – 12:00h Aula Magna de la facultad ESTCE de la Universitat Jaume I.


Federation of European Societies (FENS) Forum, Paris July 2022

Posters

  • Targeting neuroinflammation as a potential therapeutic intervention for altered pain sensitivity in attention-deficit hyperactivity disorder mouse model. María Meseguer-Beltran
  • Knockdown of IRS1 by AAV-shIRS1 impairs cognition in females and reduces mature spine density. Sandra Sánchez Sarasúa.


XXIX Congreso de la Sociedad Anatómica de España (SAE) Septiembre 2021

Oral presentation by Verónica Espinosa-Fernandez; Poster by María Meseguer Beltran

Abscisic Acid Treatment can rescue BDNF and IRS2 mRNA levels in a transgenic model of Alzheimer´s disease. Verónica; Fernandez-Espinosa
Targeting neuroinflammation as potential treatment for altered pain in ADHD. Maria Meseguer-Beltran


PhD defence Sandra Sánchez-Sarasúa, 12 Julio 2021


Incorporation Neurobiotec group to the Institute of Advanced Materials (INAM)- February 2021


EMBO Fellowship to Sandra Sánchez-Sarasúa 3-month internship at Dr Marc Landry´s laboratory (Bordeaux University). September 2020


Invited talk Ana M Sanchez-Pérez at University of West, Sweeden, Neuroinflammation and Insulin Resistance: at the crossroad for neurological and psychiatric disorders. December 2019